A tough 2023, but better than the large-cap market

2023 saw a decreased level of dealmaking. High costs of energy, interest rates and soaring inflation reduced the availability of debt, forced up company costs and fostered a valuation mismatch between potential buyers and sellers. But transactions continued to get done for the small number of high-quality mid-market assets put up for sale. Lincoln International’s analysis of its private equity (PE)-backed mid-market deals in Europe showed that, in many cases, assets were sold with robust multiples. At 13.2x, the fourth quarter showcased the most positive median EV / LTM EBITDA transaction multiples of the year, well above the two-year rate (12.7x), with healthcare performing the most positively. While sponsor-backed firms’ post-COVID-19 revenue growth continued to decline in the deals Lincoln analyzed, margin compression reduced because of ongoing EBITDA growth.

On the private credit side, distress levels in 2023 were modest within the mid-market companies Lincoln valued in Europe (and the U.S.), with just 2% of businesses falling into that category, based on fair values. The proportion of companies defaulting on covenants continued to decline throughout the year, to 3.4% in the fourth quarter, way below the 9.4% peak during the pandemic. Throughout 2023, lenders worked closely with borrowers to help them manage their positions. Unsurprisingly, the consumer and retail sectors faced the greatest proportion of defaults (8.9% of companies), more than double those of the same quarter last year.

Deal-drivers for 2024

With inflation reduced from its recent highs, a significantly decreased cost of energy (natural gas in particular) and the expectation that interest rates have peaked and could start falling from around the middle of the year, the macroeconomic picture in Europe is much more stable than it has been for months.

Debt financing is becoming increasingly available from banks, including through their direct lending divisions as well as syndicated loans, and debt funds, typically now providing more creative deal structures to get transactions done, often including payment-in-kind (PIK) and unitranche options.

There is a huge volume of dry power waiting to be deployed, around $2.59 trillion in PE and $400 billion in direct lending, and corporates are in a strong position to ramp up their acquisition strategies as they typically carry less leverage than PE-backed companies.

On the sell side, whereas in 2023 many financial sponsors held onto portfolio assets rather than bring them to market, the more stable economic environment, and the increasing availability of debt for buyers will encourage owners to seek an exit. There is also the pressure on PE firms to generate liquidity for their investors by selling portfolio companies before the cycle of generating new funds can begin as well as through mechanisms such as continuation vehicles and dividend recaps. A further catalyst to dealmaking is likely to come from the many private company owners, perhaps at the later stage of their careers. Having survived two crises in quick succession, they rationally want to diversify their wealth by bringing their business or at least part of it to market.

As ever, deal dynamics will vary by sector and asset type, but in many cases, financial sponsors and vendors will have to accept the higher interest rate paradigm of considerably lower valuations. Given the confluence of deal drivers, the valuation mismatch of the last 18 months keeping assets off the market will become a factor of the past.

Lincoln has a strong backlog of M&A deals, and we are seeing a significant increase in new pitch requests. We anticipate that many of these deals will come to market towards the end of Q2 and into Q3. The technology, media and telecom industry has been the hardest-hit M&A sector since the pandemic, and we expect it to experience a rapid recovery. Energy transition, artificial intelligence (AI) and environmental, social and governance (ESG) assets are in strong demand, and we will continue to see transactions based on diversifying from dependence on China as a manufacturing base. We anticipate a step-up in take privates, corporate carve-outs—some following shareholder activism—distressed sales and takeovers by public companies riding elevated stock market valuations.

Bumps in the road?

While the 2024 outlook is positive, the global geopolitical outlook remains highly uncertain, and the playout of events could hamper M&A recovery. Top concerns include an escalation of unrest in Gaza into a wider regional conflict, further drawing in the U.S. and Europe and lengthening supply chains as more volume is forced around South Africa instead of through the Suez Canal, as well as the ongoing tension between the U.S. and China, including about Taiwan.

Dealmakers will also closely monitor the outcome of the U.S. election, with likely greater protectionism if Trump returns to the presidency as it may put a brake on some transactional areas. However, when Trump was President, his protectionist approach and tax subsidies for European investment drove companies to seek acquisitions of U.S. companies rather than relying on exports to the country. The UK election is likely to be another critical moment for M&A as the UK Labour Party, which is expected to come to power, has plans to significantly increase the taxation rate of carried interest on PE deals. But regardless of any geopolitical outcome, the U.S. will remain by far the most important target and buyer nation for European companies due to its market value.

Contributors

Meet Professionals with Complementary Expertise in Europe

Related Perspectives

Forecasting Success: Mid-market European M&A Set for Active 2024

2023 was a slower year for mergers and acquisitions (M&A), but the private mid-market fared better than the large-cap arena. Globally, the elements are in place for 2024 to be… Read More

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Lincoln International Leader Recognized as Woman of Influence in Finance

Lincoln International is pleased to share that the Los Angeles Business Journal named Ashleigh Barker, Director in Lincoln’s Consumer Group, as a woman of influence in finance. “Ashleigh Barker is… Read More

Rohit Nigam

Rohit Nigam

Rohit provides mergers and acquisitions (M&A) and capital advisory services to private equity firms and privately owned companies in the financial institutions industry. Prior to joining Lincoln, Rohit was an… Read More

Bart Jaspers

Bart Jaspers

Bart provides buy-side and sell-side mergers and acquisitions (M&A) advisory services to private equity firms, entrepreneurs and corporations, with a focus on the Benelux region. Bart collaborates closely with his… Read More

Jim O'Malley

Jim O’Malley

Jim specializes in providing sell-side and buy-side mergers and acquisitions advisory (M&A) services to a diverse clientele, including private equity firms, business owners and both public and private companies within… Read More

Thomas Anderson

Thomas specializes in mergers and acquisitions (M&A) advisory services in Lincoln’s Technology Group. He has significant experience advising both domestic and cross-border transactions for leading private equity firms, public companies… Read More

Distribution M&A: Outlook on 2024

The distribution sector has faced a series of challenges initiated and driven by the COVID-19 epidemic over the past several years. These have included changes directly attributable to the epidemic,… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More

Packaging Quarterly Review Q4 2023

Mergers and acquisitions (M&A) markets closed Q4 2023 in a similar vein to previous quarters, with a decline in completed deals. The packaging market closely followed suit, also experiencing a… Read More

Supplements – A Bright Spot in the Pet Industry

As we embark on a new year, it’s an opportune time to reflect on the “bright spots” within the pet industry that present exciting prospects, particularly as the pet industry… Read More

Beauty Independent | The Prognosis for Beauty M&A and Early-Stage Funding in 2024

Originally posted by Beauty Independent on January 22, 2024. Mergers and acquisitions (M&A) activity in the beauty market is on the up. “Looking forward, the recent deal announcements support the… Read More

Lincoln International adds Lalit Kasat as Managing Director in London

Lincoln International, a global investment banking advisory firm, is pleased to announce that Lalit Kasat has joined as a Managing Director in the firm’s Technology, Media & Telecom (TMT) Group… Read More

Bradley Hale

Bradley provides buy-side and sell-side mergers and acquisitions (M&A) advisory services to private equity firms, public companies and privately owned businesses in the technology industry, with a focus on software.… Read More

Beatriz Cabrero

Beatriz provides mergers and acquisitions advisory services to private equity firms, entrepreneurs and family-owned and multinational companies, with a focus on the food and beverage, consumer products, apparel and beauty… Read More

Lucas Naumann

Lucas provides mergers and acquisitions (M&A) advisory services to private equity firms and privately held businesses, with a focus on Software as a Service, human capital management and enterprise technology.… Read More

Lalit Kasat 616x616

Lalit Kasat

Lalit provides mergers and acquisitions advisory and growth equity fundraising services to private equity firms, founders and corporations in the technology industry, with a focus on business-to-business (B2B) software, data… Read More

VentureCapital Magazin | Courageous Decisions Needed: Commentary on the 2024 German M&A Market

Originally posted by VentureCapital Magazin on January 5, 2024. Rising interest rates, increased energy costs, geopolitical conflicts and poor economic forecasts led to a slower German mergers and acquisitions (M&A)… Read More

Scrip Asks…What Does 2024 Hold for Biopharma?

James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series. Part One – Business Strategy and Leadership… Read More

Lisa Weigel

Lisa provides buy-side and sell-side mergers and acquisitions advisory services to private equity firms, small and medium-sized enterprises, entrepreneurs and multinational corporates in the industrials industry. Lisa harnesses her deep… Read More

Lincoln International Announces Promotions to Drive Ongoing Organizational & Client Success

Lincoln International, a global investment banking advisory firm, today announced the appointment of several firm leaders into executive management and client advisory roles. The firm has promoted Mary Weber to… Read More

Vincent Smulders

Vincent provides mergers and acquisitions advisory services to private equity firms, corporates and entrepreneurs in the industrials and healthcare industries. Vincent works closely with his clients, guiding them through each… Read More

2023 Global Results

Just Food | Cautious Optimism Oozes Around Food M&A Outlook in 2024 as Risks Fester

Originally posted by Just Food on December 14, 2023. While deal activity in the food industry has slowed, businesses that passed on pricing and kept their volumes from going backward… Read More

Sustainability in Focus for Packaging M&A

The packaging industry faces a paradigm shift amidst a growing public conversation on climate change and, as a result, the concerted endeavors of governments worldwide to regulate single-use packaging and… Read More